Conor Tweed
Royal Free London NHS Foundation Trust(GB)MRC Clinical Trials Unit at UCL(GB)North Middlesex Hospital(GB)University College London(GB)Middlesex University(GB)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Statistical Methods in Clinical Trials, Diagnosis and treatment of tuberculosis, Health Systems, Economic Evaluations, Quality of Life, Advanced Causal Inference Techniques
Most-Cited Works
- → Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis(2022)528 cited
- → Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial(2019)146 cited
- → Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies(2016)89 cited
- → Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study(2018)74 cited
- → A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB(2021)62 cited
- → Erratum to: ‘Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies’